Article
<i>ethA</i> , <i>inhA</i> , and <i>katG</i> Loci of Ethionamide-Resistant Clinical <i>Mycobacterium tuberculosis</i> Isolates
24 Nov 2003
Abstract excerpt
Ethionamide (ETH) is a structural analog of the antituberculosis drug isoniazid (INH). Both of these drugs target InhA, an enzyme involved in mycolic acid biosynthesis. INH requires catalase-peroxidase (KatG) activation, and mutations in katG are a major INH resistance mechanism. Recently an enzyme (EthA) capable of activating ETH has been identified. We sequenced the entire ethA structural gene of 41...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
